Targeted drug distribution in tumor extracellular fluid of GD2-expressing neuroblastoma patient-derived xenografts using SN-38-loaded nanoparticles conjugated to the monoclonal antibody 3F8

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

Alice L. Yu, Andrew L. Gilman, M. Fevzi Özkaynak et al. · New England Journal of Medicine · 2010 · 1.8K citations · Full text

Medicine, Immunology, Oncology +14

Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile

Jeffrey S. Hrkach, Daniel D. Von Hoff, Mir Mukkaram Ali et al. · Science Translational Medicine · 2012 · 1.1K citations

Pharmacy, Pharmaceutics, Pharmacology +17

Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes

Yoko S. DeRose, Guoying Wang, Yi‐Chun Lin et al. · Nature Medicine · 2011 · 1K citations · Full text

Medicine, Cancer Biology, Oncology +17

Enhanced Tumor Trafficking of GD2 Chimeric Antigen Receptor T Cells by Expression of the Chemokine Receptor CCR2b

John Craddock, An Lu, Adham S. Bear et al. · Journal of Immunotherapy · 2010 · 502 citations · Full text

Life Sciences, Immunology, Oncology +17

The pediatric preclinical testing program: Description of models and early testing results

Peter J. Houghton, Christopher L. Morton, Chandra L. Tucker et al. · Pediatric Blood & Cancer · 2006 · 483 citations

Medicine, Oncology, Cancer Pharmacology +14